Drug Quality: The Future of Indian Pharma Hinges on Patient Trust, Says Dr. Sujit Paul

• Dr. Sujit Paul, Group CEO, Zota Healthcare Ltd., emphasizes that drug quality is the foundation of patient trust, especially for India as "the pharmacy of the world."
• Global scrutiny, recalls, and contamination concerns highlight drug quality as a reputational imperative, requiring trust to be earned repeatedly.
• Three pillars define drug quality: science (efficacy validation), systems (GMP, automation for consistent manufacturing), and surveillance (pharmacovigilance, post-market monitoring).
• Patients are becoming informed, quality-conscious consumers, demanding proof over just price, driven by QR codes and online information.
• Affordability and quality are not opposing goals; ethical sourcing and stringent testing can ensure cost-effective, high-quality medicines.

Why It Matters: Indian pharma's future success depends on consistently proving drug quality to build and maintain patient trust globally.